Francisco Javier
Burgos Revilla
Catedrático/a de Universidad
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublications en collaboration avec des chercheurs de University of Texas Southwestern Medical Center (3)
2023
-
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy
Minerva urology and nephrology, Vol. 75, Núm. 5, pp. 591-599
2022
-
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancer
Urologic Oncology: Seminars and Original Investigations, Vol. 40, Núm. 11, pp. 491.e11-491.e19
-
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES–UTUC registry
World Journal of Urology, Vol. 40, Núm. 11, pp. 2755-2763